General MedicationsINJECTIONStandard
PACLITAXEL
PACLITAXEL
Standard Dose
6MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview PACLITAXEL is listed in Drugs@FDA under application 216874 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient PACLITAXEL Form and strength INJECTABLE;INJECTION - 6MG/ML Sponsor ALEMBIC Submission history Latest submission status date: 2022-10-20 00:00:00.
Structured Monograph
Clinical summary
Approval overview PACLITAXEL is listed in Drugs@FDA under application 216874 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient PACLITAXEL Form and strength INJECTABLE;INJECTION - 6MG/ML Sponsor ALEMBIC Submission history Latest submission status date: 2022-10-20 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.